The fix sits upstream of the site list.
A Market Feasibility Test (MFT) screens real patients against a protocol's eligibility criteria before site selection.
One Parkinson's MFT drew 214 patient responses. Only 4% qualified, yet 100% of qualified patients asked to be connected to a study team.
Adding clinical research sites would have screened the same population to the same result.
This brief shows why the site-adding reflex exists, what it costs, and how an MFT confirms recruitment potential before a single site is selected.
Download it before sizing your next site network.
Download it before sizing your next site network.
